Targeted Genomic Sequencing for Genetic Disorders in Newborns
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new blood test designed to detect rare genetic diseases in newborns in the neonatal intensive care unit (NICU). The main goal is to determine if this test, called targeted genomic sequencing, can accurately identify genetic changes related to a baby's health issues compared to standard methods. The study requires taking a tiny blood sample from the infant, just once. Babies who might qualify for this trial include those with unusual results on standard newborn tests, unexplained low muscle tone, seizures, abnormal lab results, or joint and bone problems. As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research that could improve early diagnosis and treatment for newborns.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What prior data suggests that this genomic sequencing method is safe for newborns?
Research has shown that targeted genomic sequencing is generally safe and well-tolerated for newborn screening. Studies have found that this method can successfully identify genetic disorders in babies, leading to better health outcomes. No specific reports of negative effects from the sequencing itself exist. The process involves taking a very small blood sample, about one-tenth of a teaspoon, making it a low-risk procedure. Since targeted genomic sequencing is already used in various ways for newborn screening, it indicates a level of safety for this application.12345
Why are researchers excited about this trial?
Targeted genomic sequencing is unique because it offers a precise way to identify genetic disorders in newborns, something current methods like standard newborn screening or karyotyping cannot do with the same level of detail. Researchers are excited about this technique because it can quickly pinpoint the exact genetic mutations causing a disorder, potentially allowing for faster and more accurate diagnosis. This speed and accuracy could lead to earlier interventions and better outcomes for affected infants, setting it apart from traditional, broader approaches that might take longer to yield results.
What evidence suggests that this genomic sequencing method is effective for identifying genetic disorders in newborns?
Research has shown that targeted genomic sequencing, which participants in this trial will undergo, effectively identifies genetic disorders in newborns. In one study, 13% of newborns received at least one possible diagnosis based on the genetic information found. This method is nearly twice as effective as traditional methods, offering faster results at a lower cost. Additionally, targeted genomic sequencing can significantly benefit health by enabling doctors to start preventive measures or treatments based on the findings. The technology's ability to quickly provide useful information makes it a promising tool for diagnosing rare genetic conditions in infants.678910
Are You a Good Fit for This Trial?
This trial is for infants in the NICU with suspected genetic disorders. They must be able to provide a small blood sample. Specific inclusion and exclusion criteria are not listed, but typically involve health status and parental consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Sample Collection
Participants provide a very small (one-tenth of a teaspoon) sample of blood, one-time
Analysis
Prototype genomic blood analysis is conducted to identify genetic variations
Follow-up
Participants are monitored for safety and effectiveness after analysis
What Are the Treatments Tested in This Trial?
Interventions
- Targeted genomic sequencing
Trial Overview
Researchers are testing a new genomic blood test designed to quickly identify rare diseases in newborns. It will be compared against traditional genome sequencing methods to check its accuracy.
How Is the Trial Designed?
All participants who meet inclusion and exclusion criteria and whose parent has provided written informed consent.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sharp HealthCare
Lead Sponsor
MedySapiens
Collaborator
Citations
A Genomic Sequencing Approach to Newborn Mass ...
In this cohort study of 4054 newborns, 13.0% received at least 1 possible diagnosis based on pathogenic or likely pathogenic variants detected ...
A Genomic Sequencing Approach to Newborn Mass ...
This cohort study examines the feasibility, potential utility, and clinical implications of next-generation sequencing–based newborn ...
3.
radygenomics.org
radygenomics.org/2023/genome-sequencing-effective-diagnosing-genetic-disorders-newborns-infants-gemini-study/Genome Sequencing Nearly Twice as Effective as a ...
Targeted genome sequencing was found to deliver routine results more quickly and at a lower cost; lack of standardization in analytic ...
Data-driven consideration of genetic disorders for global ...
Over 30 international studies are exploring newborn sequencing (NBSeq) to expand the range of genetic disorders included in newborn screening.
Feasibility, acceptability and clinical outcomes of the ...
Average time to genomic newborn result was 13 days. Clinical impact ranged from instituting preventative measures or surveillance to active ...
Newborn Screening by Genomic Sequencing
As occurred with MSMS, next generation sequencing (NGS) offers the promise of screening for more disorders at lower overall cost per disease.
BeginNGS Publications | RCIGM
Genome-sequence-based newborn screening (gNBS) has substantial potential to improve outcomes in hundreds of severe childhood genetic disorders (SCGDs).
Population-based, first-tier genomic newborn screening in ...
A workflow was developed to screen newborns for 165 treatable pediatric disorders by deep sequencing of regions of interest in 405 genes.
Genome Sequencing for Newborn Screening
The introduction of genome sequencing into newborn screening has the potential to dramatically improve health outcomes for newborns with genetic ...
The case against genomic sequencing of healthy newborns
Sequencing targeted at infants with suspected genetic conditions can help make an early diagnosis which can impact treatment, and it is ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.